Journal
CLINICA CHIMICA ACTA
Volume 413, Issue 3-4, Pages 378-383Publisher
ELSEVIER
DOI: 10.1016/j.cca.2011.10.032
Keywords
ANP; Biomarker; BNP; Corin; Heart failure; Membrane protease
Categories
Funding
- National Natural Science Foundation of China [31070716]
- Natural Science Foundation of the Jiangsu Higher Education Institutions [10KJB320017]
- Jiangsu Higher Education Institutions of China
- Bakken Heart-Brain Institute
- Research Project Committee of the Cleveland Clinic
- NIH [HL089298]
Ask authors/readers for more resources
Corin is a transmembrane serine protease identified in the heart, where it converts natriuretic peptides from inactive precursors to mature active forms. Studies in animal models and patients with hypertension and heart disease demonstrate that corin is critical in maintaining normal blood pressure and cardiac function. Like many proteolytic enzymes, corin expression and activity are regulated. Cell biology experiments indicate that transcriptional control, intracellular protein trafficking, cell surface targeting, zymogen activation and ectodomain shedding are important mechanisms in regulating corin expression and activity in the heart. More recently, soluble corin was detected in human blood and its levels were found to be reduced in patients with heart failure (HF). These findings indicate that corin deficiency may be involved in the pathogenesis of HF and suggest that soluble corin may be used as a biomarker for the disease. In this review, we describe the function and regulation of corin and discuss recent studies of soluble corin in human blood and its potential use as a biomarker for HF. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available